WT1 and acute lymphoblastic leukemia: The oncogene Wilms’ Tumor 1 (WT1), normally overexpressed in ALL, is also a potential indirect target of miR-15a and miR-16-1; lowering WT1 gene levels promotes the proliferative blockade of leukemic cells [17].